Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

dSir2 and Dmp53 interact to mediate aspects of CR-dependent lifespan extension in D. melanogaster.

Aging | 2009

Calorie Restriction (CR) is a well established method of extending life span in a variety of organisms. In the fruit fly D. melanogaster, CR is mediated at least in part by activation of dSir2. In mammalian systems, one of the critical targets of Sir2 is the tumor suppressor p53. This deacetylation of p53 by Sir2 leads to inhibition of p53's transcriptional activity. We have recently shown that inhibition of Dmp53 activity in the fly brain through the use of dominant-negative (DN) constructs that inhibit DNA-binding can extend life span. This life span extension appears to be related to CR, as CR and DN-Dmp53 donot display additive effects on life span. Here we report that life span extension by DN-Dmp53 expression is highly dynamic and can be achieved even when DN-Dmp53 is expressed later in life. In addition, we demonstrate that life span extension by activation of dSir2 and DN-Dmp53 expression are not additive. Furthermore, we show that dSir2 physically interacts with Dmp53 and can deacetylate Dmp53-derived peptides. Taken together, our data demonstrate that Dmp53 is a down stream target of dSir2 enzymatic activity and mediates some aspects of the life span extending effects of CR.

Pubmed ID: 19851477 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIA NIH HHS, United States
    Id: R01 AG025277
  • Agency: NIA NIH HHS, United States
    Id: R01 AG016667-05
  • Agency: NIA NIH HHS, United States
    Id: K25 AG028753
  • Agency: NIA NIH HHS, United States
    Id: R37 AG016667
  • Agency: NIA NIH HHS, United States
    Id: RF1 AG024353
  • Agency: NIA NIH HHS, United States
    Id: AG25277
  • Agency: NIA NIH HHS, United States
    Id: R01 AG024353-05
  • Agency: NIA NIH HHS, United States
    Id: AG24353
  • Agency: NIA NIH HHS, United States
    Id: R01 AG025277-04
  • Agency: NIA NIH HHS, United States
    Id: R01 AG024353
  • Agency: NIA NIH HHS, United States
    Id: AG16667
  • Agency: NIA NIH HHS, United States
    Id: K99 AG029723
  • Agency: NIA NIH HHS, United States
    Id: R01 AG016667
  • Agency: NIA NIH HHS, United States
    Id: K99AG029723

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


BIOMOL (tool)

RRID:SCR_013545

An Antibody supplier

View all literature mentions

BioRad Helios Gene Delivery System (tool)

RRID:SCR_019723

Handheld gene delivery system that provides direct transfection into a range of targets in vivo. It uses adjustable low pressure helium pulse to sweep DNA, RNA, or biomaterial coated gold microcarriers from a plastic cartridge directly into target cells.

View all literature mentions